Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-04-06 @ 11:46 AM
Study NCT ID:
NCT00354068
Status:
COMPLETED
Last Update Posted:
2013-03-28
First Post:
2006-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-19
First Submit QC Date:
None
Study First Post Date:
2006-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-26
Last Update Post Date:
2013-03-28
Last Update Post Date Type:
ESTIMATED